期刊文献+

卵巢癌腹主动脉旁淋巴结转移相关因素分析及其意义 被引量:2

Analysis of related factors of abdominal aortic lymph node metastasis in ovarian cancer and its significance
下载PDF
导出
摘要 目的探讨上皮性卵巢癌腹主动脉旁淋巴结转移的相关因素及其意义。方法回顾性分析2012年1月~2015年5月于我院行系统性盆腔及腹主动脉旁淋巴结切除术的上皮性卵巢癌患者56例的临床资料。结果 56例中腹膜后淋巴结转移26例(46.43%),其中同时有盆腔及腹主动脉旁淋巴结转移19例(33.93%),单独盆腔淋巴结转移4例(15.38%),单纯腹主动脉旁淋巴结转移3例(5.36%)。腹主动脉淋巴结转移占39.29%(22/56),其中腹主动脉旁左侧转移72.73%(16/22),腹主动脉右侧转移27.27%(6/22),腹主动脉及下腔静脉间转移13.64%(3/22),左肾静脉水平淋巴结转移40.91%(9/22)。Logistic分析结果示组织学分级、FIGO分期、病灶位于双侧卵巢是盆腔淋巴结转移的独立危险因素,盆腔淋巴结转移是腹主动脉旁淋巴结转移的独立危险因素。随访3~46个月,复发12例,其中腹主动脉旁淋巴结转移7例,Log-rank检验提示腹主动脉旁淋巴结转移者生存曲线低于无转移者。COX分析结果显示:腹主动脉旁淋巴结转移及病灶位于双侧卵巢是卵巢癌复发的独立危险因素。结论存在高危因素的卵巢癌患者有必要行腹主动脉旁淋巴结切除术,有能力时需切除至左肾静脉水平,降低卵巢癌复发率,改善预后。
出处 《实用妇科内分泌电子杂志》 2016年第4期56-59,共4页 Electronic Journal of Practical Gynecological Endocrinology
  • 相关文献

参考文献9

  • 1Timmers PJ,Zwinderman K,Coens C,Vergote I,Trimbos JB.Lymph node sampling and taking of blind biopsies are important elements of the surgical staging of early ovarian eancer[J].Int J Gyneeol Cancer,2010,20:1142-7. 被引量:1
  • 2曹泽毅.妇科肿瘤学[M].北京:北京人民出版社,2001.832~837. 被引量:4
  • 3Onda T, Yoshikawa H,Yokota H,et al.Assessment of metastases to aortic and pelvic lymph nodes in epithelial ovarian carcinoma. A proposal for essential sites for lymph node biopsy[J]. Cancer, 1996,78(4): 803-808. 被引量:1
  • 4Chang SJ,Bristow RE,Ryu HS.Analysis of para-aortie lymphadenectomy up to the level of the renal vessels in apprent early-stage ovarian eaneer[J].J Gyneeol Oncol,2013,24( 1 ):29-36. 被引量:1
  • 5Harter P, Gnauert K,Hils R, et al. Pattern and clinical predictors of lymph node metastases in epithelial ovarian cancer[J].Int J Gyneeol Cancer,2007,17(6): 1238-1244. 被引量:1
  • 6党彩玲,李力,阳志军.复发上皮性卵巢癌化疗疗效的Meta分析[J].国际妇产科学杂志,2014,41(3):290-297. 被引量:6
  • 7宋坤,孔北华.上皮性卵巢癌的临床研究进展[J].现代妇产科进展,2013,22(7):527-533. 被引量:19
  • 8Goukos G,Angioli R.Role of lymphadenectomy in ovarian cancer. Best Pratt Res Clin Obstet Gynaecol,2002,16:529-551. 被引量:1
  • 9林仲秋,杨清元.卵巢癌复发的相关因素[J].中国实用妇科与产科杂志,2005,21(7):386-387. 被引量:2

二级参考文献75

  • 1曹泽毅,于莎莎.妇科恶性肿瘤治疗后一年内未控与复发原因的研究——附全国61所医院1753例分析[J].中华妇产科杂志,1996,31(7):417-421. 被引量:21
  • 2Bristow RE, Lagasse LD, Karlan BY. Secondary surgical cytoreduction for advanced epithelial ovarian cancer: patient selection and review of the literature. Cancer,1996,78(10):2049-2062 被引量:1
  • 3Tay EH,Grant PT,Gebski V, et al. Secondary cytoreductive surgery for recurrent epithelial ovarian cancer. Obstet Gynecol, 2002,99(6):1008-1013 被引量:1
  • 4Mutch DG. Surgery for recurrent epithelial ovarian cancer. Semin Oncol,2002,29(Suppl 1):3-8 被引量:1
  • 5Gadducci A,Iacconi P,Cosio S ,et al.Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer. Gynecol Oncol,2000,79(3):344-349 被引量:1
  • 6American Cancer Society. Cancer Facts & Figures 2012 [ C ]. Atlanta : American Cancer Society ,2012. 被引量:1
  • 7Lynch HT, Lynch JF, Conway TA. Hereditary ovarian canc- er. In : Rubin SC, Sutton GP, eds. Ovarian cancer[ M ]. New York : McGraw-Hill, 1993 : 189-217. 被引量:1
  • 8Roukos DH, Briasoulis E. Individualized preventive and therapeutic management of hereditary breast ovarian canc- er syndrome[ J]. Nat Clin Pract Oncol,2007,4(10) :578- 90. 被引量:1
  • 9Anderson GL,Judd HL, Kaunitz AM,et al. Effects of estro- gen plus progestin on gynecologic cancers and associated diagnostic procedures:the Women's Health Initiative ran- domized trial[ J]. JAMA,2003,290 (13) : 1739-1748. 被引量:1
  • 10Lacey JV Jr, Mink PJ, Lubin JH, et al. Menopausal hor- mone replacement therapy and risk of ovarian cancer[J] JAMA, 2002,288 (3) :334-341. 被引量:1

共引文献26

同被引文献39

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部